Genus Lifesciences Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 514 North 12th Street, Allentown, Pennsylvania (PA) 18102, United States (USA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3003851100 · DUNS 113290444
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2024-07-31
- VAIDrug Quality Assurance2019-09-20
- NAIBioresearch Monitoring2018-11-28
- VAIDrug Quality Assurance2018-07-20
- VAIDrug Quality Assurance2017-09-29
- NAIBioresearch Monitoring2016-08-11
- VAIDrug Quality Assurance2014-10-17
- NAIBioresearch Monitoring2012-12-05
- NAIDrug Quality Assurance2011-12-08
- OAIDrug Quality Assurance2011-02-03
- VAIDrug Quality Assurance2009-07-07
Drugs this plant is listed as making
7 distinct drugs across 22 products name this site in their FDA label.
- Chlorpromazine HydrochlorideSandoz, Inc.
- cocaine hydrochlorideLXO US Inc.
- Hydrocodone Bitartrate and Homatropine MethylbromideGenus Lifesciences Inc.
- LEVOTHYROXINE and LIOTHYRONINEGenus Lifesciences
- Oxycodone HydrochlorideGenus Lifesciences Inc.
- PhenobarbitalGenus Lifesciences
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.